nach oben

Acta Neurologica Belgica

Erschienen in:

01.03.2012 | Review Article

Therapeutic challenges in a patient with POEMS syndrome and recurrent stroke: presentation of a case and review of the literature

verfasst von: Björn Sommer, Jens Schaumberg

Erschienen in: Acta Neurologica Belgica | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

POEMS syndrome includes the clinical features of polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes. A severe complication of patients with this syndrome is ischemic stroke, which has been described only occasionally despite the hematologic abnormalities that may be associated with the disease. In the literature, only eight patients have been reported as suffering from multiple or recurrent strokes until now. We present a 54-year-old woman from Sri Lanka with POEMS syndrome who experienced recurrent ischemic strokes followed by an acute abdomen and global heart failure. On the basis of a literature review, we discuss current therapeutic approaches and their possible side effects.

Bardwick PA, Zvaifler NJ, Gill GN, Newman D, Greenway GD et al (1980) Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature. Medicine (Baltimore) 59:311–322

Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM et al (2003) POEMS syndrome: definitions and long-term outcome. Blood 101:2496–2506PubMedCrossRef

Dispenzieri A (2007) POEMS syndrome. Blood Rev 21:285–299PubMedCrossRef

Kuwabara S, Dispenzieri A, Arimura K, Misawa S (2008) Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome. Cochrane Database Syst Rev:CD006828

Kang K, Chu K, Kim DE, Jeong SW, Lee JW et al (2003) POEMS syndrome associated with ischemic stroke. Arch Neurol 60:745–749PubMedCrossRef

Dupont SA, Dispenzieri A, Mauermann ML, Rabinstein AA, Brown RD Jr (2009) Cerebral infarction in POEMS syndrome: incidence, risk factors, and imaging characteristics. Neurology 73:1308–1312PubMedCrossRef

Schaumberg J, Müller-Habich C, Müller-Jensen A (2010) POEMS syndrome: difficult to diagnose, difficult to treat. Akt Neurol 37:86–88CrossRef

Forster A, Müri R (1998) Rezidivierende zerebrovaskuläre Insulte—Manifestation des POEMS-Syndroms? Schweiz Med Wochenschr 128:1059–1064PubMed

Rössler M, Kiessling B, Klotz JM, Langohr HD (2004) Recurrent cerebral ischemias due to cerebral vasculitis associated with incomplete POEMS syndrome with Castleman disease. Nervenarzt 75:790–794PubMed

10.

Lee MR, Choi HJ, Lee EB, Baek HJ (2007) POEMS syndrome complicated by extensive arterial thromboses. Clin Rheumatol 26:1989–1992PubMedCrossRef

11.

Garcia T, Dafer R, Hocker S, Schneck M, Barton K et al (2007) Recurrent strokes in two patients with POEMS syndrome and Castleman’s disease. J Stroke Cerebrovasc Dis 16:278–284PubMedCrossRef

12.

Zenone T, Bastion Y, Salles G, Rieux C, Morel D et al (1996) POEMS syndrome, arterial thrombosis and thrombocythaemia. J Intern Med 240:107–109PubMedCrossRef

13.

Lesprit P, Authier FJ, Gherardi R, Bélec L, Paris D et al (1996) Acute arterial obliteration: a new feature of the POEMS syndrome? Medicine (Baltimore) 75:226–232CrossRef

14.

Scarlato M, Previtali SC, Carpo M, Pareyson D, Briani C et al (2005) Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis. Brain 128:1911–1920PubMedCrossRef

15.

Kristinsson SY (2010) Thrombosis in multiple myeloma. Hematology Am Soc Hematol Educ Program 437–444

16.

Ipek Y, Fehmi H, Sevgi BK, Deniz S (2011) Thrombotic complications in multiple myeloma: a report of three cases and review of the literature. J Thromb Thrombolysis. doi:10.1007/s11239-011-0636-z

17.

Geeganage C, Wilcox R, Bath PM (2010) Triple antiplatelet therapy for preventing vascular events: a systematic review and meta-analysis. BMC Med 8:36PubMedCrossRef

18.

Balucani C, Barlinn K, Zivanovic Z, Parnetti L, Silvestrini M et al (2010) Dual antiplatelet therapy in secondary prevention of ischemic stroke: a ghost from the past or a new frontier? Stroke Res Treat. doi:10.4061/2010/427418

19.

Kaygusuz I, Tezcan H, Cetiner M, Kocakaya O, Uzay A et al (2010) Bortezomib: a new therapeutic option for POEMS syndrome. Eur J Haematol 84:175–177PubMedCrossRef

20.

Li J, Zhang W, Jiao L, Duan MH, Guan HZ et al (2011) Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome. Blood 117:6445–6449PubMedCrossRef

Titel: Therapeutic challenges in a patient with POEMS syndrome and recurrent stroke: presentation of a case and review of the literature
verfasst von: Björn Sommer
Jens Schaumberg
Publikationsdatum: 01.03.2012
Verlag: Springer Milan
Erschienen in: Acta Neurologica Belgica / Ausgabe 1/2012
Print ISSN: 0300-9009
Elektronische ISSN: 2240-2993
DOI: https://doi.org/10.1007/s13760-012-0012-6

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

25.04.2024 | Hypotonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Therapeutic challenges in a patient with POEMS syndrome and recurrent stroke: presentation of a case and review of the literature

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2012

Dilative arteriopathy in metabolic myopathies, particularly Pompe’s disease

Giant cell ependymoma of the thoracic spinal cord

Hallucinations in Parkinson’s disease: cross-sectional study

Diffusion restriction in the splenium of the corpus callosum in a patient with the syndrome of transient headache with neurological deficits and CSF lymphocytosis (HaNDL): a challenge to the diagnostic criteria?

Prediction of hospitalization duration for acute stroke in Belgium

Diagnostic approach of patients with longitudinally extensive transverse myelitis

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie